Goldman Sachs leads gainers among the 30 stocks in the Dow Jones Industrial Average; Bank of America up handily

Goldman Sachs Group Inc.’s stock GS, +4.42% is the biggest gainer among the 30 stocks in the Dow Jones Industrial Average DJIA, +0.66% at midday Friday with a rise of 4%. The stock has risen 12.6% so far this week. It’s also on pace for largest percent increase since November 10, 2022, when it rose …

Baker Hughes data show a fall in the weekly active U.S. oil-drilling rig count

Baker Hughes BKR, -0.34% on Friday reported that the number of active U.S. rigs drilling for oil fell by 8 to 496 this week. That followed three consecutive weeks of increases. The total active U.S. rig count, which includes those drilling for natural gas, also declined by 7 to stand at 618, according to Baker …

Oil futures post losses for the session and week

Oil futures declined on Friday, with U.S. prices tallying a loss of 5.9% for the week, according to Dow Jones Market Data. All of the softer U.S. economic data may have come as a relief to Federal Reserve policymakers, but “it’s weighed on crude oil, with a weaker economy meaning softer demand,” said Craig Erlam, …

Dow transports have best week in a year, to snap longest weekly losing streak in 5 years

The Dow Jones Transportation Average DJT, +1.59% rallied 1.7% in afternoon trading, with 18 of 20 components gaining ground, as part of a broader stock market rally. The index was headed for a fifth-straight gain as it has run up 7.2% this week. That would not only be the best one-week performance since it climbed …

U.S. stocks close higher Friday, score biggest weekly gains in about a year

U.S. stocks closed sharply higher Friday, extending a monster rally in equities that saw the big three indexes sweep to their biggest weekly gains of 2023. The Dow Jones Industrial Average DJIA, +0.66% rose about 222 points, or 0.7%, ending near 34,061 on Friday to score a 5.1% weekly gain, according to preliminary FactSet data. …

CVS Health shares fall as company cuts full-year profit outlook

CVS Health Corp.’s stock CVS, +1.48% fell more than 4% premarket Wednesday, after the drug-store chain and health-services company posted stronger-than-expected third-quarter earnings but cut profit guidance for the full year and sounded downbeat on its 2024 outlook. The company had net income of $2.265 billion, or $1.75 a share, for the quarter, after a …

Humana Q3 net income, revenue beats analyst estimate

Humana Inc.’s stock HUM, -3.21% rose 0.3% in premarket trading on Wednesday after the health insurance company’s third-quarter net income and revenue beat analyst estimates. Humana said its third-quarter profit fell to $1.1 billion, or $6.71 a share, from $1.3 billion, or $9.39 a share, in the year-ago quarter. The company’s third-quarter adjusted profit of …

Crispr’s stock soars as FDA panel raises hopes for sickle-cell-disease drug

Crispr Therapeutics AG’s stock rallied 12% Wednesday, after a positive meeting of a Food and Drug Administration advisory panel on a treatment for sickle-cell disease raised hopes it will win regulatory approval. The gene-editing drug, called exa-cel, is being developed by Crispr CRSP, +8.10% and partner Vertex Pharmaceuticals VRTX, +0.79%. The FDA has set a …

Estee Lauder stock plunges to a 6-year low after profit outlook disappoints

Shares of Estée Lauder Companies Inc. plunged toward a six-year low Wednesday after the beauty-products company reported a surprise fiscal first-quarter profit but provided a second-quarter outlook that was well below expectations and slashed its full-year forecast. “While we had a better-than-expected first quarter, we are lowering our fiscal 2024 outlook given incremental external headwinds, …

Kraft Heinz stock jumps after profit beat and raised outlook, while sales came up short

Shares of Kraft Heinz Co. KHC, +2.35% rallied 1.7% in premarket trading Wednesday, after the consumer food and beverage giant topped third-quarter profit expectations and lifted its full-year outlook, while sales came up a bit shy. Net income fell to $262 million, or 21 cents a share, from $432 million, or 35 cents a share, …